Melphalan is a chemotherapy drug belonging to the class of nitrogen mustard
alkylating agents. An alkylating agent adds an alkyl group to DNA. It attaches the
Drug type: Melphalan is an anti-cancer ("antineoplastic" or "cytotoxic")
chemotherapy drug. This medication is classified as an "alkylating agent." (For
more detail ...
Jan 23, 2014 ... The chemotherapy drug melphalan can treat myeloma, advanced ovarian cancer
and advanced breast cancer. The possible side effects ...
Mar 28, 2016 ... This page contains brief information about melphalan and a collection of links to
more information about the use of this drug, research results, ...
Jun 8, 2011 ... WARNING. ALKERAN (melphalan) should be administered under the
supervision of a qualified physician experienced in the use of cancer ...
Aug 15, 2012 ... Melphalan can cause a severe decrease in the number of blood cells in your
bone marrow. This may cause certain symptoms and may ...
Jan 3, 2016 ... Alkeran (melphalan) is a drug prescribed for the treatment of multiple myeloma
and ovarian cancer. Side effects of Alkeran include weight loss, ...
Find patient medical information for melphalan oral on WebMD including its uses,
side effects and safety, interactions, pictures, warnings and user ratings.
An alkylating nitrogen mustard that is used as an antineoplastic in the form of the
levo isomer – melphalan, the racemic mixture – merphalan, and the dextro ...
Melphalan is an alkylating nitrogen mustard that is used as an antineoplastic in
the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, ...